1 / 9

O.D.260 Inc

O.D.260 Inc. Biotech company 5 employees State-of-the-art equipment on 1,700 sf, SE Boise Mission: Becoming a leader in the development and sales of innovative tools for biological research. Our Technologies. Adenovirus-based Vectors for Gene Transfer Gene studies Gene Therapy Vaccines

coye
Download Presentation

O.D.260 Inc

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. O.D.260 Inc • Biotech company • 5 employees • State-of-the-art equipment on 1,700 sf, SE Boise • Mission: Becoming a leader in the development and sales of innovative tools for biological research.

  2. Our Technologies • Adenovirus-based Vectors for Gene Transfer • Gene studies • Gene Therapy • Vaccines • Detection and Analysis of Promoters • Unique high-throughput method to discover and analyze gene switches

  3. O.D.260 Inc Business Activities • Research & Development • Services • Adenovirus custom cloning services • Promoter analysis • Sales of tool kits (www.od260.com) • Adenovirus cloning kits • Promoter detective method

  4. Short-term Plan • Web site + e-commerce • Product launch / custom services • Advertisement • More R&D (Promoter Phase II) • New collaborations • Patents

  5. Long-term Plan • Increase our market share by diversification of our product lines • Establish new partnerships • License our technologies to other companies (fee or through partnerships and collaborations) • Hire personnel

  6. Our Story • Mid 90’s : an idea • 1999 : Inc • 2001 : SBIR Phase I • 2003-2004 : investment ~ $ 450K • 2004 : SBIR Phase II • 2004 : a Home! • 2005 : SBIR Phase I

  7. Our Resources • Education (4 PhD + 1 MS) • Experience (70+ years in molecular biology) • SBIR program (NIH: 2 x Phase I + 1 x Phase II) • ISBDC/TECenter (Burt Knudson, Rick Ritter) • Economic downfall for others, opportunities for us • Personal saving accounts

  8. What we bring to Idaho • Employment • High-value Technologies • Collaborations with experts worldwide (Idaho, US, Europe, Asia) • Help for others (“we have been there”)

  9. What Idaho should (continue to) do in order to create or attract biotech businesses • Support basic science, to foster new ideas, which will create new products and business opportunities • Get a technology incubator with biotech capabilities • More flexibility from institutions • Leadership • Support from State Representatives and Senators.

More Related